Pharmacology · Antimicrobials (Cell Wall Inhibitors, Protein Synthesis Inhibitors, Fluoroquinolones)

A patient on linezolid for MRSA pneumonia develops serotonin syndrome after starting an SSRI. Which mechanism explains this interaction?

  • A Linezolid inhibits serotonin reuptake
  • B Linezolid inhibits CYP2D6
  • C Linezolid causes serotonin release
  • D Linezolid is a reversible MAO-A inhibitor
Correct answer: D. Linezolid is a reversible MAO-A inhibitor

Explanation

Linezolid is a weak, reversible monoamine oxidase D inhibitor. When combined with SSRIs, it increases synaptic serotonin, risking serotonin syndrome. It does not inhibit CYP2A6 or directly cause serotonin release. This interaction is a key safety concern with oxazolidinones.

Reference: Katzung: Basic & Clinical Pharmacology, 14th ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Antimicrobials (Cell Wall Inhibitors, Protein Synthesis Inhibitors, Fluoroquinolones) MCQs

See all Antimicrobials (Cell Wall Inhibitors, Protein Synthesis Inhibitors, Fluoroquinolones) MCQs →